• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS EXERA II GASTROINTESTINAL VIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS EXERA II GASTROINTESTINAL VIDEOSCOPE Back to Search Results
Model Number GIF-H180
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Perforation (2001)
Event Date 11/09/2021
Event Type  Injury  
Manufacturer Narrative
This device is not available to return for evaluation.Attached is a copy of the literature.The investigation is ongoing.A supplemental report will be submitted upon completion of the investigation or when additional information becomes available.
 
Event Description
Olympus medical systems corp.(omsc) received a literature titled, "retrospective analysis of the outcomes of endoscopic submucosal dissection for the diagnosis and treatment of subepithelial lesions in a center with high expertise." this study aimed to assess the diagnostic and therapeutic utility of endoscopic submucosal dissection (esd) for the management of subepithelial lesions (sels) in a tertiary esd referral center.A total of 634 esds were reviewed, 55 (9%) were performed in sels, (6 in the esophagus, 34 in the stomach, and 15 in the rectum).Neuroendocrine tumors, gastrointestinal stromal tumors, and granular cell tumors accounted for 38% of the procedures, with a 100% rate of en bloc resection and 65% of r0 resection; the main criterion for non-curative resection was a deep positive margin, and none of the patients treated with complementary surgery had lesions on the gastrointestinal wall.The reasons for esd in these lesions were the uncertainty of the diagnosis after eus evaluation and, in 1 case, also the lesion growth between 2 eus (anectopic pancreas).Esd can be an effective treatment for sels, even with lower curative rates comparing to procedures on epithelial lesions.Type of adverse events/number of patients perforation (granular cell tumor in the esophagus, closure with endoscopic clipping) (1 patient) bleeding after discharge needing readmission (1 patient) needed hemostasis with clips during esd (1 patients) delayed bleeding (2 patients) (b)(6) - dual-knives (kd-650l (single use electrosurgical knife kd-650)) (b)(6) - insulated tip (it)-2 (kd-611l (single use electrosurgical knife)) (b)(6) - it-nano knives (kd-612l (single use electrosurgical knife kd-612)) (b)(6) - coagrasper (fd-410lr (single use electrosurgical hemostatic forceps)) (b)(6) - high definition endoscopes (gif-h180 (evis exera ii gastrointestinal videoscope)) (b)(6) - high definition endoscopes (gif-h190 (evis exera iii gastrointestinal videoscope)) this report is for (b)(6).
 
Manufacturer Narrative
This supplemental report is being submitted to provide additional information from the author and to provide additional information based on the legal manufacturer's final investigation.New information added to the following fields: b5 and h6.The device history record was unable to be reviewed for this device as no serial number was provided.Based on the results of the investigation, it is likely the reported event is an accident, or a complication associated with a surgical procedure using the subject device.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Olympus will continue to monitor field performance for this device.
 
Event Description
Olympus further received information from the author/physician that the events describe in the study are considered normal for the technique used.Furthermore, the physician confirmed that no olympus device contribute to the events described in the study.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA II GASTROINTESTINAL VIDEOSCOPE
Type of Device
GASTROINTESTINAL VIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer (Section G)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key16892625
MDR Text Key314801105
Report Number9610595-2023-07227
Device Sequence Number1
Product Code FDS
UDI-Device Identifier04953170339776
UDI-Public04953170339776
Combination Product (y/n)N
Reporter Country CodePO
PMA/PMN Number
K100584
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 06/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberGIF-H180
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 04/09/2023
Initial Date FDA Received05/08/2023
Supplement Dates Manufacturer Received05/18/2023
Supplement Dates FDA Received06/13/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
KD-650L, KD-611L, KD-612L, FD-410LR, GIF-H190.
Patient Outcome(s) Hospitalization; Required Intervention;
-
-